Table 1 Clinical data of two groups
From: Severity of COVID-19 infection in patients with COVID-19 combined with diabetes
Variable | Good blood glucose control group (N = 53) | Poor blood glucose control group (N = 93) | Statistics | P |
|---|---|---|---|---|
Age/Year | 74(66.5 ∼ 83.5) | 74(64.5 ∼ 83) | -0.499(z) | 0.618 |
Sex/Case | 1.578(c2) | 0.209 | ||
Male | 28(53%) | 59(63%) | ||
Female | 25(47%) | 34(37%) | ||
CRP | 18.91(4.53 ∼ 96.88) | 44.12(15.71 ∼ 107.16) | -1.960(z) | 0.050 |
Leukocyte | 5.75(4.71 ∼ 7.16) | 6.84(4.81 ∼ 8.5) | -2.055(z) | 0.400 |
Lymphocyte | 1.02(0.75 ∼ 1.32) | 0.96(0.61 ∼ 1.31) | -0.669(z) | 0.500 |
Clinical classification | 5.329(c2) | 0.021 | ||
Common | 28(53%) | 31(33%) | ||
Critical | 25(47%) | 62(67%) | ||